Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0078 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.018 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0065 | 1 |